Austin Charette - 08 Jan 2026 Form 3 Insider Report for AGENUS INC (AGEN)

Reporting relationship
Principal Accounting Officer
Issuer ticker
AGEN
Reported as of
08 Jan 2026
Net transaction value
$0
Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
3
Accepted by SEC
16 Jan 2026, 16:05:11 UTC
Next SEC filing
23 Mar 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
By: /s/ Austin Charette

Key filing fact

Austin Charette filed Form 3 for AGENUS INC (AGEN) on 16 Jan 2026.

Key facts

  • This page summarizes Austin Charette's Form 3 filing for AGENUS INC (AGEN).
  • 0 reported transactions and 11 derivative rows are listed below.
  • Accepted by SEC: 16 Jan 2026, 16:05.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0002105444 Primary reporting owner

Charette Austin

Relationship
Principal Accounting Officer
Address
3 FORBES ROAD, LEXINGTON
Signature
By: /s/ Austin Charette
Signature date
16 Jan 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AGEN holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
9,115
Date
08 Jan 2026
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

AGEN holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
08 Jan 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
337
Exercise price
$74.40
AGEN holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
08 Jan 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
101
Exercise price
$113.00
AGEN holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
08 Jan 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
237
Exercise price
$47.60
AGEN holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
08 Jan 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
325
Exercise price
$82.40
AGEN holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
08 Jan 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
375
Exercise price
$74.00
AGEN holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
08 Jan 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
375
Exercise price
$63.60
AGEN holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
08 Jan 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
375
Exercise price
$64.40
AGEN holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
08 Jan 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
375
Exercise price
$49.00
AGEN holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
08 Jan 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
4,843
Exercise price
$12.26
AGEN holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
08 Jan 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
625
Exercise price
$12.26
Footnotes
F1
AGEN holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
08 Jan 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
625
Exercise price
$3.02
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Options awarded in accordance with the Agenus Inc. 2019 Equity Incentive Plan (as amended), which vested as to one third of the underlying shares on January 16, 2025, and the balance in equal quarterly installments thereafter, generally subject to continued employment.

Footnote F2

Options awarded in accordance with the Agenus Inc. 2019 Equity Incentive Plan (as amended) and vests over three years with one third vesting on the one-year anniversary of the grant date (May 28, 2025) and the balance in equal quarterly installments thereafter, generally subject to continued employment.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .